Eledon Pharmaceuticals (ELDN) Institutional Ownership → Americans Now Need $1.46M to Retire… (From Crypto 101 Media) (Ad) Free ELDN Stock Alerts $2.80 +0.29 (+11.55%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Eledon Pharmaceuticals (NASDAQ:ELDN)CurrentInstitutional OwnershipPercentage56.77%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$4.04MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$68.12K Get ELDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELDN Institutional Buying and Selling by Quarter Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Eledon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024 CM Management LLC160,000$330K0.3%+14.3%0.645% 5/10/2024 Vanguard Group Inc.969,121$2.00M0.0%+39.4%3.906% 2/13/2024 Armistice Capital LLC2,189,000$3.94M0.1%+20.0%9.045% 11/15/2023 Armistice Capital LLC1,824,000$2.50M0.0%-1.0%7.538% 10/19/2023 Jmac Enterprises LLC58,041$80K0.0%-27.5%0.246% 8/15/2023 BVF Inc. IL4,326,710$5.93M0.2%+86.0%18.372% Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/11/2023 SVB Financial Group18,025$25K0.0%-33.1%0.080% 7/20/2023 Jmac Enterprises LLC80,041$110K0.0%+46.8%0.356% 2/9/2023 CM Management LLC234,800$535K0.6%-4.2%1.706% 11/14/2022 Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894% 11/14/2022 Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726% 11/14/2022 Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160% 11/4/2022 CM Management LLC245,000$676K0.8%+8.9%1.781% 8/16/2022 Woodline Partners LP516,675$1.26M0.0%-23.2%3.755% 5/9/2022 CM Management LLC225,000$887K0.7%+95.7%1.636% 4/25/2022 Bailard Inc.27,600$109K0.0%N/A0.193% 2/14/2022 Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016% 2/11/2022 Ensign Peak Advisors Inc77,100$340K0.0%+966.7%0.539% 2/7/2022 Ameritas Advisory Services LLC24,219$107K0.0%N/A0.169% 2/2/2022 CM Management LLC115,000$507K0.4%+53.3%0.804% 11/16/2021 Two Sigma Advisers LP115,900$716K0.0%+48.0%0.810% 11/16/2021 Two Sigma Investments LP115,324$713K0.0%+100.5%0.806% 11/16/2021 BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530% 11/15/2021 Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464% 11/15/2021 Eversept Partners LP114,008$705K0.1%N/A0.797% 11/15/2021 Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051% 11/10/2021 Mercer Global Advisors Inc. ADV16,726$103K0.0%N/A0.117% 8/18/2021 Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446% 8/17/2021 Woodline Partners LP857,445$6.78M0.1%-3.8%5.993% 8/17/2021 Boothbay Fund Management LLC40,052$317K0.0%+39.6%0.280% 8/16/2021 Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319% 8/16/2021 Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948% 8/16/2021 State Street Corp32,935$261K0.0%N/A0.230% 8/13/2021 Renaissance Technologies LLC21,107$167K0.0%-22.0%0.148% 8/13/2021 Northern Trust Corp32,116$254K0.0%+106.8%0.224% 8/13/2021 Geode Capital Management LLC124,614$985K0.0%+25.7%0.871% 8/13/2021 Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466% 5/19/2021 Logos Global Management LP224,071$2.40M0.2%N/A1.566% 5/18/2021 BVF Inc. IL1,113,435$11.91M0.4%N/A7.782% 5/18/2021 Millennium Management LLC14,588$156K0.0%N/A0.102% “Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now.5/18/2021 Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874% 5/18/2021 Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894% 5/18/2021 Citadel Advisors LLC25,062$268K0.0%N/A0.175% 5/17/2021 Woodline Partners LP891,055$9.53M0.2%N/A6.228% 5/17/2021 EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798% 5/17/2021 Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495% 5/17/2021 Ikarian Capital LLC250,000$2.68M0.1%N/A1.747% 5/13/2021 Renaissance Technologies LLC27,051$289K0.0%N/A0.189% 5/12/2021 Northern Trust Corp15,528$166K0.0%N/A0.109% 5/12/2021 Geode Capital Management LLC99,123$1.06M0.0%N/A0.693% 5/12/2021 CM Management LLC75,000$803K0.6%N/A0.524% 5/7/2021 BlackRock Inc.12,282$131K0.0%N/A0.086% 4/21/2021 Ingalls & Snyder LLC51,149$547K0.0%N/A0.358% (Data available from 1/1/2016 forward) ELDN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELDN shares? During the previous two years, 10 institutional investors and hedge funds held shares of Eledon Pharmaceuticals. The most heavily invested institutionals were BVF Inc. IL ($5.93M), Armistice Capital LLC ($3.94M), Cormorant Asset Management LP ($3.38M), Vanguard Group Inc. ($2.00M), Woodline Partners LP ($1.26M), Point72 Asset Management L.P. ($1.04M), and CM Management LLC ($330K).Learn more on ELDN's institutional investors. What percentage of Eledon Pharmaceuticals stock is owned by institutional investors? 56.77% of Eledon Pharmaceuticals stock is owned by institutional investors. Learn more on ELDN's institutional investor holdings. Which institutional investors have been buying Eledon Pharmaceuticals stock? The following institutional investors have purchased Eledon Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($2M), Armistice Capital LLC ($365K), Vanguard Group Inc. ($273.70K), CM Management LLC ($40K), and Jmac Enterprises LLC ($25.50K). How much institutional buying is happening at Eledon Pharmaceuticals? Institutional investors have bought a total of 2,704,206 shares in the last 24 months. This purchase volume represents approximately $4.09M in transactions. Which Eledon Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Eledon Pharmaceuticals stock in the last 24 months: Woodline Partners LP ($156.46K), Cormorant Asset Management LP ($81.60K), Point72 Asset Management L.P. ($53.36K), Jmac Enterprises LLC ($22K), Armistice Capital LLC ($18.80K), Boothbay Fund Management LLC ($12.58K), and CM Management LLC ($10.20K). How much institutional selling is happening at Eledon Pharmaceuticals? Institutional investors have sold a total of 363,918 shares in the last 24 months. This volume of shares sold represents approximately $880.34K in transactions. Related Companies: BLRX Institutional Ownership CELU Institutional Ownership RPHM Institutional Ownership ANVS Institutional Ownership IMMX Institutional Ownership CALC Institutional Ownership GANX Institutional Ownership AEON Institutional Ownership CKPT Institutional Ownership AADI Institutional Ownership This page (NASDAQ:ELDN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe #1 Investment of the Decade… Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Nvidia WarningAltimetryThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
